These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 14189284)
1. EFFECTS OF VASOPRESSORS AND BLOCKING AGENTS ON THE KIDNEY IN OLIGEMIA. GIOJUBS RW; SIMEONE FA Surg Forum; 1964; 15():12-3. PubMed ID: 14189284 [No Abstract] [Full Text] [Related]
2. HEMODYNAMIC ACTION OF VASOPRESSOR AND VASODEPRESSOR AGENTS IN ENDOTOXIN SHOCK. MORRIS JA; SMITH RW; ASSALI NS Am J Obstet Gynecol; 1965 Feb; 91():491-503. PubMed ID: 14259138 [No Abstract] [Full Text] [Related]
3. METABOLIC RESPONSES TO VARIOUS VASOACTIVE AND CARDIOTONIC AGENTS IN HYPOVOLEMIA. UNAL M; WEBB WR; ASLAMI A Surg Forum; 1964; 15():25-7. PubMed ID: 14189357 [No Abstract] [Full Text] [Related]
4. Metabolic effects of vasopressors and vasodilators in the hypovolemia of standard hemorrhagic shock. WEBB WR; SHAHBAZI N; JACKSON J Surg Forum; 1960; 10():378-82. PubMed ID: 13843274 [No Abstract] [Full Text] [Related]
5. HEMODYNAMIC EFFECTS OF VASOPRESSOR AGENTS IN HEMORRHAGIC SHOCK. MILLS LC; STEPPACHER R Am J Cardiol; 1963 Nov; 12():614-8. PubMed ID: 14075986 [No Abstract] [Full Text] [Related]
6. LYMPH FLOW PATTERNS UNDER THE INFLUENCE OF PRESSOR AMINES, GANGLIONIC BLOCKING AGENTS, AND HEMORRHAGIC SHOCK. PEARL GJ; TRANK JW; GURD FN; HAMPSON LG Surg Forum; 1963; 14():14-6. PubMed ID: 14064491 [No Abstract] [Full Text] [Related]
7. EVALUATION OF RENAL FUNCTION IN SHOCK WITH THE RADIOISOTOPE RENOGRAM. KRETCHMAR LH; GREENE WM; MCDONALD DF Surg Gynecol Obstet; 1963 Dec; 117():733-7. PubMed ID: 14100522 [No Abstract] [Full Text] [Related]
8. Effects of adrenergic blocking agents on renal blood flow in normovolemia and experimental hypovolemia. Muhm HY; Shumacker HB Ann Surg; 1966 Jul; 164(1):51-60. PubMed ID: 5947294 [No Abstract] [Full Text] [Related]
9. REGIONAL BLOOD FLOW ALTERATIONS. STUDIES OF CHANGES IN THIS COURSE PRODUCED BY A VASOCONSTRICTOR AND AN ADRENERGIC BLOCKING AGENT DURING READJUSTMENT TO HEMORRHAGIC SHOCK. POLLOCK L; KJARTANSSON KB; DELIN NA; SCHENK WG Arch Surg; 1964 Aug; 89():344-54. PubMed ID: 14160163 [No Abstract] [Full Text] [Related]
11. RESPONSES OF ADRENAL CORTICOSTEROID SECRETION TO HYPOTENSION AND HYPOVOLEMIA. GANN DS; EGDAHL RH J Clin Invest; 1965 Jan; 44(1):1-7. PubMed ID: 14254252 [No Abstract] [Full Text] [Related]
12. THE USE OF DRUGS IN THE TREATMENT OF IRREVERSIBLE VASOCONSTRICTOR SHOCK. FITTS CT; SAWYER RB J Trauma; 1965 Jan; 5():11-5. PubMed ID: 14255170 [No Abstract] [Full Text] [Related]
13. EFFECTS OF VASOPRESSORS ON THE MICROCIRCULATION AND ON SURVIVAL IN HEMORRHAGIC SHOCK. HERSHEY SG; MAZZIA VD; ALTURA BM; GYURE L Anesthesiology; 1965; 26():179-89. PubMed ID: 14261053 [No Abstract] [Full Text] [Related]
14. A COMPARISON OF THE PHYSIOLOGIC EFFECTS OF ANGIOTENSIN WITH OTHER VASOCONSTRICTORS. REA VE; KIRKSEY TD; DERRICK JR; ARTZ CP Surg Forum; 1964; 15():17-8. PubMed ID: 14189311 [No Abstract] [Full Text] [Related]
15. Pharmacological agents in experimental hemorrhagic shock. A controlled comparison of treatment with hydralazine, hydrocortisone, and levarterenol (1-norepinephrine). HAKSTIAN RW; HAMPSON LG; GURD FN Arch Surg; 1961 Sep; 83():335-47. PubMed ID: 13710650 [No Abstract] [Full Text] [Related]